{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:18:30Z","timestamp":1785280710581,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H04892"],"award-info":[{"award-number":["15H04892"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08073"],"award-info":[{"award-number":["19K08073"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111462","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:29:37Z","timestamp":1615249777000},"page":"111462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein"],"prefix":"10.1016","volume":"138","author":[{"given":"Motohiro","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiroyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2021.111462_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/epi.13638","article-title":"Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein","volume":"58","author":"Wood","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.biopha.2021.111462_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2012.03.056","article-title":"Levetiracetam inhibits neurotransmitter release associated with CICR","volume":"518","author":"Fukuyama","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111462_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111462_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0028-3908(03)00248-X","article-title":"Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?","volume":"45","author":"Madeja","year":"2003","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2021.111462_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cns.12347","article-title":"Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons","volume":"21","author":"Niespodziany","year":"2015","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2021.111462_bib7","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1111\/epi.13890","article-title":"Brivaracetam does not modulate ionotropic channels activated by glutamate, gamma-aminobutyric acid, and glycine in hippocampal neurons","volume":"58","author":"Niespodziany","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-017-8621-x","article-title":"Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis","volume":"265","author":"Hu","year":"2018","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.biopha.2021.111462_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0000000000002545","article-title":"Brivaracetam add-on for refractory focal epilepsy: a systematic review and meta-analysis","volume":"86","author":"Lattanzi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2021.111462_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2016.05.004","article-title":"Levetiracetam vs. brivaracetam for adults with refractory focal seizures: a meta-analysis and indirect comparison","volume":"39","author":"Zhang","year":"2016","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.biopha.2021.111462_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1212\/WNL.0000000000002864","article-title":"Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies","volume":"87","author":"Ben-Menachem","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2021.111462_bib12","first-page":"1","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/bcp.13296","article-title":"Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies","volume":"83","author":"Zaccara","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111462_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ane.12044","article-title":"Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine","volume":"196","author":"Svalheim","year":"2013","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"6","key":"10.1016\/j.biopha.2021.111462_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tips.2016.03.001","article-title":"Anti-Inflammatory small molecules to treat seizures and epilepsy: from bench to bedside","volume":"37","author":"Dey","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2021.111462_bib16","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.3390\/ijms20153727","article-title":"Carbamazepine attenuates astroglial L-glutamate release induced by pro-inflammatory cytokines via chronically activation of adenosine A2A receptor","volume":"20","author":"Okada","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2021.111462_bib17","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1111\/bph.14491","article-title":"Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites","volume":"175","author":"Fukuyama","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111462_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2013.08.002","article-title":"Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway","volume":"76 Pt A","author":"Fukuyama","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111462_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1476-5381.2012.02132.x","article-title":"ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation","volume":"168","author":"Yamamura","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.biopha.2021.111462_bib20","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.3390\/ijms21218142","article-title":"Age-dependent and sleep\/seizure-induced pathomechanisms of autosomal dominant sleep-related hypermotor epilepsy","volume":"21","author":"Okada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/bph.14974","article-title":"Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant alpha4 subunit of nicotinic ACh receptor","volume":"177","author":"Fukuyama","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111462_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110070","article-title":"Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant \u03b14 subunit of nicotinic ACh receptor","volume":"126","author":"Fukuyama","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ph13040058","article-title":"Upregulated connexin 43 induced by loss-of-functional S284L-mutant \u03b14 subunit of nicotinic ACh receptor contributes to pathomechanisms of autosomal dominant sleep-related hypermotor epilepsy","volume":"13","author":"Fukuyama","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2021.111462_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/ph13050099","article-title":"Upregulated and hyperactivated thalamic connexin 43 plays important roles in pathomechanisms of cognitive impairment and seizure of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant \u03b14 subunit of nicotinic ACh receptor","volume":"13","author":"Fukuyama","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2021.111462_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/ph13060117","article-title":"Effects of carbamazepine, lacosamide and zonisamide on gliotransmitter release associated with activated astroglial hemichannels","volume":"13","author":"Fukuyama","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/ijms22010339","article-title":"Astroglial connexin43 as a potential target for a mood stabiliser","volume":"22","author":"Okada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2021.111462_bib27","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.3390\/ijms21197019","article-title":"A working hypothesis regarding identical pathomechanisms between clinical efficacy and adverse reaction of clozapine via the activation of connexin43","volume":"21","author":"Okada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111462_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/cells9020414","article-title":"Activation of astroglial connexin is involved in concentration-dependent double-edged sword clinical action of clozapine","volume":"9","author":"Fukuyama","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2021.111462_bib29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1476-5381.2011.01638.x","article-title":"Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes","volume":"165","author":"Tanahashi","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111462_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.116.3.761","article-title":"Synaptic vesicle membrane proteins interact to form a multimeric complex","volume":"116","author":"Bennett","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111462_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2019.07.015","article-title":"Protective role of levetiracetam against cognitive impairment and brain white matter damage in mouse prolonged cerebral hypoperfusion","volume":"414","author":"Inaba","year":"2019","journal-title":"Neuroscience"},{"issue":"16","key":"10.1016\/j.biopha.2021.111462_bib32","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British Journal of Pharmacology: updated guidance for 2020","volume":"177","author":"Lilley","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111462_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/biom9060234","article-title":"Clozapine normalizes a glutamatergic transmission abnormality induced by an impaired NMDA receptor in the thalamocortical pathway via the activation of a group III metabotropic glutamate receptor","volume":"9","author":"Fukuyama","year":"2019","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.biopha.2021.111462_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/biom9050191","article-title":"Amantadine combines astroglial system Xc\u2212activation with glutamate\/NMDA receptor inhibition","volume":"9","author":"Nakano","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.457","article-title":"Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc(\u00b7)","volume":"7","author":"Okada","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib36","doi-asserted-by":"crossref","first-page":"E573","DOI":"10.1073\/pnas.1121557109","article-title":"Trafficking of gap junction channels at a vertebrate electrical synapse in vivo","volume":"109","author":"Flores","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brainres.2006.02.139","article-title":"Relevance of astrocytic activation to reductions of astrocytic GABAA receptors","volume":"1089","author":"Tateishi","year":"2006","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.111462_bib38","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/ijms19113645","article-title":"Cystine\/glutamate antiporter and aripiprazole compensate NMDA antagonist-induced dysfunction of thalamocortical L-glutamatergic transmission","volume":"19","author":"Fukuyama","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1476-5381.2009.00175.x","article-title":"Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex","volume":"157","author":"Yamamura","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111462_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/biom10070990","article-title":"Interaction between mesocortical and mesothalamic catecholaminergic transmissions associated with NMDA receptor in the locus coeruleus","volume":"10","author":"Okada","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.biopha.2021.111462_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111462_bib42","first-page":"S142","article-title":"The concise guide to pharmacology 2019\/20: ion channels","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"D1","key":"10.1016\/j.biopha.2021.111462_bib43","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"The IUPHAR\/BPS guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111462_bib44","first-page":"S1","article-title":"THE concise guide to pharmacology 2019\/20: introduction and other protein targets","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111462_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pneurobio.2016.01.003","article-title":"Astrocytes as new targets to improve cognitive functions","volume":"144","author":"Dallerac","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib46","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1528-1167.2007.01135.x","article-title":"Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation","volume":"48","author":"Somera-Molina","year":"2007","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.biopha.2021.111462_bib47","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.25641","article-title":"Therapeutic drug monitoring of newer antiepileptic drugs: a randomized trial for dosage adjustment","volume":"87","author":"Aicua-Rapun","year":"2020","journal-title":"Ann. Neurol."},{"issue":"01\/02","key":"10.1016\/j.biopha.2021.111462_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2021.111462_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2147\/DDDT.S154388","article-title":"Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines","volume":"12","author":"Reimers","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2021.111462_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0920-1211(99)00010-8","article-title":"Effects of zonisamide on K+ and Ca2+ evoked release of monoamine as well as K+ evoked intracellular Ca2+ mobilization in rat hippocampus","volume":"35","author":"Kawata","year":"1999","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111462_bib52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/glia.22318","article-title":"Astrocyte calcium signaling and epilepsy","volume":"60","author":"Carmignoto","year":"2012","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.biopha.2021.111462_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neures.2003.11.002","article-title":"Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ","volume":"48","author":"Wilhelm","year":"2004","journal-title":"Neurosci. Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib54","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1021\/acschemneuro.9b00351","article-title":"The synaptic vesicle glycoprotein 2: structure, function, and disease relevance","volume":"10","author":"Stout","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1582-4934.2006.tb00289.x","article-title":"Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions","volume":"10","author":"Butt","year":"2006","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuroscience.2004.06.008","article-title":"Potassium buffering in the central nervous system","volume":"129","author":"Kofuji","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111462_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fncel.2014.00189","article-title":"Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases","volume":"8","author":"Takeuchi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1073858414523320","article-title":"Novel astrocyte targets: new avenues for the therapeutic treatment of epilepsy","volume":"21","author":"Crunelli","year":"2015","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10571-016-0341-8","article-title":"The AMPAR antagonist perampanel attenuates traumatic brain injury through anti-oxidative and anti-inflammatory activity","volume":"37","author":"Chen","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111462_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-0102(01)00309-1","article-title":"The role of TNF-alpha in amygdala kindled rats","volume":"42","author":"Shandra","year":"2002","journal-title":"Neurosci. Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.111462_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113970","article-title":"Permeation of molecules through astroglial connexin 43 hemichannels is modulated by cytokines with parameters depending on the permeant species","volume":"21","author":"Saez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2021.111462_bib62","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14728222.2018.1539078","article-title":"Should we target TNF receptors in the intestinal epithelium with glucocorticoids during systemic inflammation?","volume":"22","author":"Van Looveren","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib63","doi-asserted-by":"crossref","first-page":"16623","DOI":"10.1038\/s41598-019-52900-4","article-title":"Blocking connexin43 hemichannels protects mice against tumour necrosis factor-induced inflammatory shock","volume":"9","author":"Delvaeye","year":"2019","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.biopha.2021.111462_bib64","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1242\/jcs.200667","article-title":"Role of connexin 43 in different forms of intercellular communication - gap junctions, extracellular vesicles and tunnelling nanotubes","volume":"130","author":"Ribeiro-Rodrigues","year":"2017","journal-title":"J. Cell Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib65","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","article-title":"Differential expression of synaptic vesicle protein 2 (SV2) isoforms","volume":"14","author":"Bajjalieh","year":"1994","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib66","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1523\/JNEUROSCI.3805-10.2011","article-title":"Protein quantification at the single vesicle level reveals that a subset of synaptic vesicle proteins are trafficked with high precision","volume":"31","author":"Mutch","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111462_bib67","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1523\/JNEUROSCI.4248-14.2015","article-title":"Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2021.111462_bib68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/35087000","article-title":"SV2 modulates the size of the readily releasable pool of secretory vesicles","volume":"3","author":"Xu","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111462_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1074\/jbc.275.1.451","article-title":"The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface","volume":"275","author":"Son","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111462_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/epi.12930","article-title":"Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking","volume":"56","author":"Garcia-Perez","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.biopha.2021.111462_bib71","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1111\/epi.14532","article-title":"Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein","volume":"59","author":"Wood","year":"2018","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.biopha.2021.111462_bib72","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/epi.12973","article-title":"Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats","volume":"56","author":"Dupuis","year":"2015","journal-title":"Epilepsia"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:16:50Z","timestamp":1760098610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":72,"alternative-id":["S075333222100247X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111462","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111462"}}